nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
|
Makvandi, Mehran |
|
2018 |
13 |
2 |
p. 189-203 |
artikel |
2 |
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
|
Purim, Ofer |
|
2018 |
13 |
2 |
p. 217-226 |
artikel |
3 |
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis
|
Schmidt, Elvira |
|
2018 |
13 |
2 |
p. 205-216 |
artikel |
4 |
Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines
|
Restelli, Valentina |
|
2018 |
13 |
2 |
p. 235-245 |
artikel |
5 |
Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression
|
Pucci, Marzia |
|
2018 |
13 |
2 |
p. 175-187 |
artikel |
6 |
Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma
|
Cochin, Valérie |
|
2018 |
13 |
2 |
p. 247-252 |
artikel |
7 |
Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences
|
Davar, Diwakar |
|
2018 |
13 |
2 |
p. 125-140 |
artikel |
8 |
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study
|
Di Bartolomeo, Maria |
|
2018 |
13 |
2 |
p. 227-234 |
artikel |
9 |
Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience
|
Alfieri, Salvatore |
|
2017 |
13 |
2 |
p. 253-256 |
artikel |
10 |
The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?
|
Hlavata, Zuzana |
|
2018 |
13 |
2 |
p. 113-123 |
artikel |
11 |
Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer
|
Choo, Joan Rou-En |
|
2018 |
13 |
2 |
p. 141-156 |
artikel |
12 |
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
|
DiGiacomo, Josh W. |
|
2018 |
13 |
2 |
p. 157-173 |
artikel |